Stevens-Johnson syndrome (SJS) is the most severe cutaneous reactions affecting skin and mucosal surfaces in pediatrics. Supportive therapy is the standard of care for SJS. The use of systemic corticosteroids has been controversial. Human intravenous immunoglobulin has been using in a number of autoimmune and cellmediated blistering disorders of the skin. We report a successful used of intravenous immunoglobulin in a child affected with SJS.

Keyword: Stevens-Johnson syndrome; Immunoglobulin; Skin lesion.